Reunião Anual da American Society of Clinical Oncology (ASCO) 2016

Preliminary Program: Friday, June 3 CSS = Clinical Science Symposium T

ED = Education Session

MTP = Meet the Professor Session (ticketed)

Primary Track

1:00 PM

The most current program is available on am.asco.org.

Sessions are listed under primary track only.

T

EXT ED = Extended Education Session

CPO = Clinical Problems in Oncology Session (ticketed)

2:00

3:00

4:00

5:00

Special Sessions Breast Cancer

T

MTP: Complex Decision Making in Clinical Practice: Interpreting HER2 Results

CSS: Breast Cancer—HER2/ER

Cancer Prev, Genetics, & Epi Care Delivery & Practice Mgmt

EXT ED: Genetics and Genomic Testing in Oncology Care EXT ED: Practicing in the Age of Value-Based Clinical Pathways

CNS Tumors

EXT ED: Multidisciplinary Management of Brain Metastases

Dev Therapeutics & Transl Res

ED: Biomarkers, BloodBased Testing, and the Heterogeneous Tumor

ED: Pharmacokinetics, Dynamics, and Genomics in the Era of Immunotherapy and Small Molecules

T

MTP: Prescribing and Managing Immunotherapy

T

CPO: Testicular Cancer: A Multidisciplinary CaseBased Discussion

GI (Colorectal) Cancer ED: HER2, VEGFR, and Beyond: Genomic Profiling of GI (Noncolorectal) Upper Gastrointestinal Tract Cancer Cancers and the Future of Personalized Treatment GU (Nonprostate) Cancer

T

MTP: Systemic and Surgical Considerations in Upper Tract Transitional Cell Carcinoma

ED: Contemporary Active Surveillance for Prostate Cancer: Do We Need Better Imaging and Molecular Testing?

ED: Intraperitoneal Chemotherapy for Ovarian Cancer: Trials and Tribulations

ED: Oligometastatic Disease in Prostate Cancer: Treating the Patient or the Scan?

GU (Prostate) Cancer Gynecologic Cancer

ED: Localized Pancreatic Cancer: Multidisciplinary Management With Incorporation of ASCO Guidelines

EXT ED: Global Oncology Clinical Science Symposium: HPV-Associated Malignancies

Head & Neck Cancer ED: NICE or Not? Evaluating Global Strategies for Sustainable Cancer Care

HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia

EXT ED: Immunotherapeutic Approaches to Treating Hematologic Malignancies

Oral Abstract Session: Hematologic Malignancies—Plasma Cell Dyscrasia

Lung Cancer Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology

Professional Development

ED: New and Improved? Use of White Blood Cell Growth Factors in Oncology Practice ED: The State of the Art in Neuroblastoma: From Biology to Survivorship

EXT ED: Heart to Heart: How to Protect the Heart During Cancer Therapy Oral Abstract Session: Pediatric Oncology I

EXT ED: Practical Tips for Academic, Private, and Industry Career Tracks: Negotiating Contracts and Education Debt Management ED: Special Session for Program Directors and Key Clinical Faculty T EXT ED: Maintenance of Certification and Lifelong Learning Workshop EXT ED: Grant Writing Workshop EXT ED: On the Shoulders of Giants: Cooperative Groups and Clinical Trial Design—Past, Present, and Future

Sarcoma Tumor Biology

REGISTER NOW AT AM.ASCO.ORG

13

Preliminary Program: Saturday, June 4 CSS = Clinical Science Symposium Primary Track

ED = Education Session

7:30 AM

8:00

9:00

CSS: Special Clinical Science Symposium #1

Special Sessions

EXT ED = Extended Education Session 10:00

11:00

Opening Session With Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture

Breast Cancer Cancer Prev, Genetics, & Epi

ED: Controversies in Genetic Evaluation

Care Delivery & Practice Mgmt

ED: The Oncology Care Model: The Man Behind the Curtain

CNS Tumors

T

MTP: Treatment of Medulloblastoma: The Devil Is in the Details

Dev Therapeutics & Transl Res GI (Colorectal) Cancer

Poster Session: Gastrointestinal (Colorectal) Cancer

GI (Noncolorectal) Cancer

Poster Session: Gastrointestinal (Noncolorectal) Cancer

GU (Nonprostate) Cancer GU (Prostate) Cancer

ED: Precision Medicine in Advanced Prostate Cancer: Understanding Genomics, Androgen Receptor Splice Variants, and Imaging Biomarkers

Gynecologic Cancer

ED: Divide and Conquer: Epithelial Gynecologic Cancers Beyond BRCA

Head & Neck Cancer

ED: Best of the Rest: Top Abstracts on Head and Neck Cancer From 2015-2016 Oncology Meetings

HSR & Quality

ED: Using Social Media, Wearables, and Electronic Medical Records to Improve Quality of Cancer Care

Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL

ED: Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?

Hematologic Malignancies— Plasma Cell Dyscrasia

ED: Defining and Redefining Myeloma Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Poster Session: Lung Cancer—Non-Small Cell Metastatic ED: Lung Cancer Screening and Prevention CPO: Real-World Issues Using Immunotherapy and Targeted T Therapies in Melanoma EXT ED: Individualizing Care for Older Adults Across the Cancer Care Continuum: Emerging Evidence and Collective Wisdom ED: Controversies in Germ-Line Genetic Testing and Disclosure in Pediatric Oncology

Lung Cancer

Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology

Professional Development

ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only)

Sarcoma Tumor Biology

14

#ASCO16 PROGRAM ANNOUNCEMENT

12:00 PM

The most current program is available on am.asco.org.

Sessions are listed under primary track only.

T

MTP = Meet the Professor Session (ticketed) 1:00

T

2:00 ASCO/American Association for Cancer Research (AACR) Joint Session: The Next Frontier of Genomics in the Clinic and Clinical Trials

CPO = Clinical Problems in Oncology Session (ticketed)

3:00

4:00

5:00

AWARD: Gianni Bonadonna Award and Lecture

Oral Abstract Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy ED: Evolving Recommendations on Prostate Cancer Screening ED: Death With Dignity or PhysicianAssisted Suicide? A Thoughtful Discussion

ED: MACRA Town Hall: Effects on Your Medicare Reimbursement Poster Discussion Session: Central Nervous System Tumors

Poster Session: Central Nervous System Tumors

ED: Clinical Trial Eligibility Criteria: Tradition Versus Reality ED: Molecular Oncology Tumor Board

Oral Abstract Session: Developmental Therapeutics—Immunotherapy Poster Discussion Session: Gastrointestinal (Colorectal) Cancer MTP: Locally Advanced T Esophageal and Gastric Cancer: When Neoadjuvant Therapy Fails ED: Elderly Patients With Bladder Cancer: Perspectives From a Surgeon, Medical, and Radiation Oncologist

T

MTP: Imaging in Rectal Cancer Poster Discussion Session: Gastrointestinal (Noncolorectal) Cancer

ED: Biliary Tract Cancer: The New and the Old

Poster Discussion Session: Genitourinary (Prostate) Cancer

Poster Session: Genitourinary (Prostate) Cancer ED: Symptom Management for the Patient with Gynecologic Cancer

T

Poster Session: Head and Neck Cancer T

MTP: Cervical Cancer Screening and Prevention in Low-Resource Countries Poster Discussion Session: Head and Neck Cancer

CPO: Challenging Cases in the Management of Head and Neck Cancer

Poster Session: Health Services Research and Quality of Care

Poster Discussion Session: Health Services Research and Quality of Care

ED: Financial Toxicity: Risks, Outcomes, and Solutions

ED: Removing Barriers to Clinical Trial Participation and Presentation of Clinical Trial Participation Awards

ED: Progress in Myeloproliferative Neoplasms: Are We Ready?

Oral Abstract Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

ED: Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, Posttransplant Lymphoproliferative Disorder T

Poster Discussion Session: Lung Cancer—Non-Small Cell LocalRegional/Small Cell/Other Thoracic Cancers

Poster Discussion Session: Lung Cancer—Non-Small Cell Metastatic Poster Discussion Session: Melanoma/Skin Cancers

Poster Session: Melanoma/Skin Cancers

ED: Differences in Approaches to Hodgkin Lymphoma Across the Adolescent and Young Adult Divide

T

CPO: Practical Tips to Engage Your Trainees, Advanced-Practice Providers, and Patients

CPO: Rare Plasma Cell Dyscrasia: Amyloid, Monoclonal Gammopathy of Renal Significance, and Waldenstrom Macroglobulinemia

ED: Cancer Treatment as an Accelerated Aging Process ED: Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors ED: Women in Oncology: A Roundtable Discussion on Professional Development

ED: Expanding the Clinically Actionable Cancer Genome

REGISTER NOW AT AM.ASCO.ORG

15

Preliminary Program: Sunday, June 5 CSS = Clinical Science Symposium

ED = Education Session

Primary Track

7:30 AM

8:00

Special Sessions

Highlights of the Day Session I

EXT ED = Extended Education Session

9:00

10:00

11:00

12:00 PM

CSS: Special Clinical Science Symposium #2

Poster Session: Breast Cancer—HER2/ER Breast Cancer Cancer Prev, Genetics, & Epi

Poster Discussion Session: Breast Cancer—HER2/ER

Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy T

MTP: Cancer Screening in Survivors

CSS: Cancer Prevention ED: Quality and Value: Measuring and Utilizing Both in Your Practice ED: The Future of Immunotherapy in Glioblastoma Poster Discussion Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Care Delivery & Practice Mgmt CNS Tumors

Dev Therapeutics & Transl Res

GI (Colorectal) Cancer GI (Noncolorectal) Cancer GU (Nonprostate) Cancer GU (Prostate) Cancer

Oral Abstract Session: Central Nervous System Tumors Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics Poster Session: Developmental Therapeutics—Immunotherapy Oral Abstract Session: Gastrointestinal (Colorectal) Cancer

Oral Abstract Session: Genitourinary (Nonprostate) Cancer T

CPO: Tumor Board on Systemic Therapies for Metastatic Prostate Cancer: Induction, Maintenance, and Sequencing

T

Gynecologic Cancer Head & Neck Cancer

Oral Abstract Session: Gynecologic Cancer Oral Abstract Session: Head and Neck Cancer ED: Opportunities for Collective Decision Making in Clinical Practice

HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia Lung Cancer Melanoma/Skin Cancers

MTP: Radium 223 in the Management of Castration-Resistant Prostate Cancer

ED: Molecularly and Phenotypically Defined Subtypes of Acute Lymphoblastic Leukemia: Implications for Management

T

MTP: Management of Acute Lymphoblastic Leukemia in Adolescent and Young Adult Patients Oral Abstract Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers CPO: Now That We Have T Immunotherapy, What Do We Do? ED: Curing High-Risk Melanoma: Are We There Yet?

Patient & Survivor Care

Oral Abstract Session: Patient and Survivor Care

ED: Cancer Survivorship: Is Every Patient’s Journey the Same? (Includes Presentation of Partners in Progress Award)

Pediatric Oncology

Oral Abstract Session: Pediatric Oncology II

AWARD: Pediatric Oncology Award and Lecture

Professional Development

ED: Training Program Directors’ Breakfast

Sarcoma

Oral Abstract Session: Sarcoma

Tumor Biology

ED: Tumor Heterogeneity and Therapeutic Resistance

16

#ASCO16 PROGRAM ANNOUNCEMENT

CPO: The Role of Chemotherapy in the Neoadjuvant, Adjuvant, and Metastatic Setting T for Patients With Soft Tissue Sarcoma: Where Do We Stand in 2016?

ED: Molecular Diagnostics in Cancer

The most current program is available on am.asco.org.

Sessions are listed under primary track only.

T

MTP = Meet the Professor Session (ticketed) 1:00

2:00

T

CPO = Clinical Problems in Oncology Session (ticketed)

3:00

Plenary Session Including the Science of Oncology Award and Lecture The Plenary Session includes abstract presentations of the top practice-changing science, with commentary from expert discussants.

4:00 Post-Plenary Discussion Session: Abstract 1

5:00 Post-Plenary Discussion Session: Abstract 2

Post-Plenary Discussion Session: Abstract 3

Post-Plenary Discussion Session: Abstract 4

Poster Discussion Session: Breast Cancer—TripleNegative/Cytotoxics/Local Therapy

ED: Optimizing Team-Based Oncology Care: Building the Village

Poster Discussion Session: Developmental Therapeutics— Immunotherapy ED: Potentially Resectable Metastatic Colorectal Cancer: A Multidisciplinary Discussion

ED: Practical Challenges in Endometrial Cancer MTP: Current State of Functional T Organ Preservation in Head and Neck Cancer ED: Defining and Measuring Quality

ED: Consolidation and Maintenance: Moving Beyond Autotransplant

ED: Treatment of Lung Cancer in Medically Compromised Patients

ED: Optimizing Palliative and End-ofLife Care: Evidence-Based Practice Improvement

T

CPO: Case Studies From the Frontline: Building Leadership Skills to Resolve Conflicts

ED: Is There a Future for Immunotherapy in Sarcoma?

REGISTER NOW AT AM.ASCO.ORG

17

Preliminary Program: Monday, June 6 CSS = Clinical Science Symposium Primary Track Special Sessions

ED = Education Session

7:30 AM

8:00

EXT ED = Extended Education Session

9:00

10:00

Highlights of the Day Session II

ASCO/European CanCer Organisation (ECCO) Joint Session: Value-Based Care

ASCO Annual Business Meeting ED: Updates and Controversies in HER2Positive Breast Cancer

ED: Breast Cancer Survivorship: Strategies for Optimal Care

Cancer Prev, Genetics, & Epi

Poster Session: Cancer Prevention, Hereditary Genetics, and Epidemiology ED: Refining Breast Cancer Risk Assessment: Additional Genes, Additional Screening T

12:00 PM ASCO Book Club

Breast Cancer

Care Delivery & Practice Mgmt

11:00

CSS: Special Clinical Science Symposium #3

ED: Access to Cancer Therapeutics in Low- and Middle-Income Countries ED: Treatment of LowGrade Gliomas in the Era of Genomic Medicine

MTP: The Contract: Employed Physicians and Shifting Incentives

CNS Tumors Dev Therapeutics & Transl Res

Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

GI (Colorectal) Cancer

CSS: Gastrointestinal (Colorectal) Cancer

GI (Noncolorectal) Cancer

Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer ED: Renal Cell Carcinoma: Systemic Treatment, Evolving TKIs, and Immuno-Oncology

GU (Nonprostate) Cancer GU (Prostate) Cancer

Oral Abstract Session: Genitourinary (Prostate) Cancer

Gynecologic Cancer

ED: Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer

Head & Neck Cancer

HSR & Quality

CSS: Gynecologic Cancer

ED: Integrating Immune Checkpoint Inhibitors and Targeted Agents with Surgery and Radiotherapy for Patients with Head and Neck Cancer MTP: Inside the Minds of Patients: Incorporating Patient-Reported T Outcomes Into Clinical Trials and Drug Approvals

CSS: Head and Neck Cancer

Oral Abstract Session: Health Services Research and Quality of Care

ED: Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?

ED: Why Are Myelodysplastic Syndromes So Difficult to Cure?

Hematologic Malignancies— Lymphoma & CLL

Poster Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Hematologic Malignancies— Plasma Cell Dyscrasia

Poster Session: Hematologic Malignancies-Plasma Cell Dyscrasia

Lung Cancer

T

MTP: Stereotactic Body Radiation Therapy or Surgery for Early-Stage Non-Small Cell Lung Cancer

Melanoma/Skin Cancers CSS: Geriatric Oncology

Pediatric Oncology

Poster Session: Pediatric Oncology

Sarcoma

Poster Session: Sarcoma

Tumor Biology

ED: What’s Next in Cancer Immunotherapy

#ASCO16 PROGRAM ANNOUNCEMENT

MTP: Diffuse Large B-Cell Lymphoma: When to Refer Patients for Radiation Therapy

ED: Metastatic Melanoma: Making the Right Treatment Choices

MTP: Melanoma Immunotherapy: Where Do We Go From Here?

AWARD: B.J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology T

ED: Curing Burnout in Oncology: Mindful Self-Compassion, Communication, and Practice

Professional Development

T

Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic

T

Patient & Survivor Care

18

Poster Discussion Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Poster Session: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Hematologic Malignancies— Leukemia, MDS, & Allotransplant

CSS: Tumor Biology

MTP: Advancing the Field of Supportive Care in Pediatric Oncology

The most current program is available on am.asco.org.

Sessions are listed under primary track only.

T

MTP = Meet the Professor Session (ticketed) 1:00

T

2:00

CPO = Clinical Problems in Oncology Session (ticketed)

3:00

4:00

5:00

ASCO/Radiological Society of North America (RSNA) Joint Session: Breast Cancer Imaging ED: Targeted Therapies in Hormone Receptor–Positive Breast Cancer

Oral Abstract Session: Breast Cancer—HER2/ER Poster Discussion Session: Cancer Prevention, Hereditary Genetics, and Epidemiology

AWARD: ASCO/American Cancer Society Award and Lecture

ED: Integrating Patient-Reported Outcomes Into Real-Life Medical Decisions CSS: Central Nervous System Tumors ED: Biomarker Tests for Molecularly Targeted Therapies: Implications and Recommendations for Practicing Oncologists and Investigators

ED: Immunotherapy: Beyond Checkpoint Inhibitors

ED: Designing Clinical Trials to Achieve Breakthrough Results in Upper Gastrointestinal Malignancies Poster Session: Genitourinary (Nonprostate) Cancer

Poster Discussion Session: Genitourinary (Nonprostate) Cancer

ED: Cytoreductive Nephrectomy in Renal Cell Carcinoma: A Debate

Poster Session: Gynecologic Cancer ED: Neoadjuvant Chemotherapy: Location, Location, Location

Poster Discussion Session: Gynecologic Cancer ED: Multimodality Management of Locoregionally Recurrent or Second Primary Head and Neck Cancer ED: Expanded Access and the Right to Try: Navigating the Intersection of Drug Development and Patient Access to Investigational Agents

Poster Discussion Session: Hematologic Malignancies— Lymphoma and Chronic Lymphocytic Leukemia

T

T

Poster Discussion Session: Hematologic Malignancies—Plasma Cell Dyscrasia

MTP: How I Treat High-Risk Multiple Myeloma

MTP: Initial Therapy for Older Patients With Chronic Lymphocytic Leukemia ED: PET-Directed Strategies in Lymphoma ED: Multiple Myeloma: Are We Ready for Personalized Therapy?

ED: Local Therapies in the Management of Oligometastatic and Metastatic Non-Small Cell Lung Cancer

CSS: Lung Cancer—Non-Small Cell Metastatic

ED: Clinical Conundrums in Melanoma Therapy

Oral Abstract Session: Melanoma/Skin Cancers Poster Session: Patient and Survivor Care ED: Rehabilitation of Patients and Survivors: Seizing the Opportunity

Poster Discussion Session: Patient and Survivor Care

Poster Discussion Session: Pediatric Oncology T

MTP: The Peer-Review Process and Writing an Outstanding Manuscript T

MTP: GISTs and Beyond: New Targets and Novel Therapies Poster Discussion Session: Sarcoma

Poster Session: Tumor Biology T

MTP: The Liquid Biopsy: Breaking out the Key Components

ED: Economic and Regulatory Implications in Drug Development for Sarcoma and Rare Cancers: The Identification of Value and Quality Poster Discussion Session: Tumor Biology

REGISTER NOW AT AM.ASCO.ORG

19

Preliminary Program: Tuesday, June 7 CSS = Clinical Science Symposium T

ED = Education Session

MTP = Meet the Professor Session (ticketed)

Primary Track

7:30 AM

The most current program is available on am.asco.org.

Sessions are listed under primary track only.

8:00

T

EXT ED = Extended Education Session

CPO = Clinical Problems in Oncology Session (ticketed)

9:00

10:00

11:00

12:00 PM

Special Sessions Highlights of the Day Session III Breast Cancer Cancer Prev, Genetics, & Epi Care Delivery & Practice Mgmt

ED: Treatment of Premenopausal Women With Endocrine-Sensitive Breast Cancer Oral Abstract Session: Cancer Prevention, Hereditary Genetics, and Epidemiology

ED: Triple-Negative Breast Cancer: Is Change on the Horizon?

ED: Less Is More: A Multidisciplinary Conversation on Treatment Options

CNS Tumors Dev Therapeutics & Transl Res

ED: Biosimilars: Here and Now ED: Debating Current Controversies in Medical Management of Metastatic Colorectal Cancer

GI (Colorectal) Cancer GI (Noncolorectal) Cancer GU (Nonprostate) Cancer GU (Prostate) Cancer Gynecologic Cancer

ED: Questions on Treatment of Locally Advanced Rectal Cancer

CSS: GU (Nonprostate) Cancer

Head & Neck Cancer HSR & Quality Hematologic Malignancies— Leukemia, MDS, & Allotransplant Hematologic Malignancies— Lymphoma & CLL Hematologic Malignancies— Plasma Cell Dyscrasia

CSS: Lymphoma CSS: Hematologic Malignancies—Plasma Cell Dyscrasia ED: Small Cell Lung Cancer: On the Move (Again?)

Lung Cancer Melanoma/Skin Cancers Patient & Survivor Care Pediatric Oncology Professional Development Sarcoma

ED: Noncytotoxic Approaches to the Treatment of Metastatic Soft Tissue Sarcoma

Tumor Biology

Oral Abstract Session: Tumor Biology

20

#ASCO16 PROGRAM ANNOUNCEMENT

ED: Immunotherapy: Beyond Anti-PD-1 and Anti-PDL1 Therapies